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Abstract 
Background: Generational differences in disease rates are 
the main subject of age-period-cohort (APC) analysis, which 
is mostly applied in cancer and suicide research. This study 
applied APC analysis to selected neurological diseases: 
amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD) 
and multiple sclerosis (MS). Methods: The analyses were 
based on Swiss mortality data. Age-stratified data has been 
available for MS, PD and ALS since 1901, 1921, and 1942, re­
spectively. APC analysis was performed within the frame­
work of log it models. Main effect models were extended by 
implementing nested effects, i.e. age effects nested in sub­
periods, in order to account for the fact that age profiles may 
change for reasons other than generational influences. Re­
sults: In preliminary analyses, APC analysis yielded notewor­
thy birth cohort effects in all three diseases. After imple­
menting nested effects, the birth cohort effects disappeared 
in ALS, and smoothed out in PD, where they were greater for 
the generations born before the 1920s. In MS, the birth co­
hort effects remained stable, and exhibited a peak in cohorts 
born in the 1910s and 1920s. Conclusions: APC analysis yield-
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ed some evidence for birth cohort effects, i.e. predisposing 
risk factors that may change in historical terms, in MS and PD, 
but probably not in ALS. Copyright© 2012 s. Karger AG, Base I 
Introduction 
In many chronic diseases, predisposing risk factors 
can occur long before the onset of the disease. A change 
in major predisposing risk factors is typically represented 
by generational change, or, in technical terms, by birth 
cohort effects, whereas immediate effects of change are 
denoted by period effects. Birth cohort effects have im­
pm·tant implications regarding disease concepts and 
research strategies. They provide unequivocal evidence 
that exogenous risk factors can be encountered early 
in life resulting in a predisposition to a chronic disease. 
Therefore, etiopathogenetic concepts need to include la­
tency or vulnerability mechanisms. Moreover, birth co­
hort effects carry the promise of finding direct clues as to 
relevant risk factors, and of introducing prevention mea­
sures in childhood or teenage years. 
Age-period-cohort (APC) analysis is the conventional 
analytical approach for deriving birth cohort effects from 
any kind of incidence, prevalence or mortality data. APC 
analysis has a long tradition in epidemiology [1, 2], nota-
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blywith regard to cancer [3, 4], and suicide research [5-7]. 
However, it has been largely overlooked in neuroepidemi­
ology. In this study we applied APC analysis to data from 
three neurological diseases, i.e. amyotrophic lateral scle­
rosis (ALS), Parkinson's disease (PD) and multiple sclero­
sis (MS). 
This study is a replication of the descriptive analysis of 
ALS, PD and MS carried out 25 years ago by Li et al. [8]. 
We appreciated the comparative approach and took the 
opportunity to shed light on these three neurological dis­
eases with a contemporary statistical analysis. In MS, the 
APC approach has been applied to Swedish data [9], 
Spanish data [10], regional Norwegian data [11], and a 
preliminary Swiss study [12], mostly providing evidence 
for birth cohort effects. To the best of our knowledge, no 
APC studies have been published with regard to ALS and 
to PD. 
Nevertheless, ALS, PD and MS seem to be promising 
candidates for detecting birth cohort effects. Firstly, sev­
eral studies have argued for an increase in incidence and 
mortality rates from MS [13], ALS [14-18], and PD [19-21] 
in Western countries during the second half of the last 
century. Whether the trends in the time series might be 
due to predisposing factors, or, rather, to immediate fac­
tors (such as change of registration practice), is an issue 
open to further analysis. Secondly, findings such as the 
seasonality of birth in ALS [22] and MS [23] have sug­
gested that predisposing risk factors might play a role in 
the etiopathogenesis of these diseases. In both instances, 
the evidence is indirect, and there have also been con­
flicting results. In PD, the encephalitis lethargica epi­
demics of the 1920s has been discussed as a possible 
source of increased birth cohort risk for developing this 
disease [24], which has led to several descriptive studies 
[19, 25]. 
This study is based on ALS , PD and MS figures dis­
played in Swiss mortality data. In ALS [26], MS [27-29], 
and PD [30] the registration level may be assumed to be 
quite high and to cover 60-90% of all patients. Of these, 
the percentage registered as underlying cause of death 
was 88% in ALS [21], between 64% [21] and 83% [31] in 
MS, and 56% in PD [21]. 
The registration practice may have changed over in­
tervening decades, thus contributing to period effects but 
not to birth cohort effects. However, if for some reason 
the change did not take place for all age groups in parallel 
[10], new age profiles might have emerged which mimic 
birth cohort effects. Accordingly, we implemented a nest­
ed approach in APC analysis to account for changing age 
profiles over the 20th century. 
Birth Cohort Effects in Neurological 
Diseases 
Materials and Methods 
Data 
Swiss mortality data is collated and published by the Federal 
Statistical Office in Bern. Systematic death certification in Swit­
zerland began in 1876, and is based on certificates that are com­
pleted by physicians [32]. Since 1969, the data has been stored on 
individual computerized records, and more detailed analyses 
have been possible, including causes of death registered as 'addi­
tional' or 'concomitant'. New classifications of the Swiss Federal 
Statistical Office followed in the periods 1901-1920, 1921-1930, 
1931-1941, 1942-1950, 1951-1967, 1968-1994 (ICDS), and since 
1995 (ICDlO). ALS has been registered since 1942, PD since 1921, 
and MS since 1901. 
With the introduction of the ICD10 coding in 1995, the num­
ber of additional causes of death (apart from the underlying 
cause) was extended from two to three causes. This implies that 
the proportion of assessed deaths may vary not only as to the 
cause of death, but also may change with time. In this study, only 
cases registered as underlying causes of death were included in the 
calculations documented below. 
For the analyses, the data was aggregated into 10-year age and 
period intervals. The sex- and age-specific population data were 
derived from Swiss census data (a census every 10 years since 
1880). 
Methods 
APC analysis is usually based on periodically (e.g. annually) 
collected age-stratified data pooled in so-called cohort tables [33]. 
The aim of APC analysis is to disentangle the different effects of 
age (age effects), historical circumstances (period effects), and 
generational succession (birth cohort effects). It is noteworthy, 
that in analyses using cohort tables with equal age and period in­
tervals, the birth cohorts are represented directly by the diago­
nals. 
APC models may be built up on variance analytic models and, 
similarly, on log-linear models [34]. Log-linear models are a vari­
ant of general linear models and are applied to categorical (cross­
tabulated) data instead of continuous data. The underlying con­
cepts are the same (main effects, interaction effects, nested ef­
fects, etc.). To be more specific, in this study we used logit analysis, 
which is a regression-like extension of log-linear models. The re­
sults of logit analysis are identical with results from logistic re­
gression, if the latter includes only categorical variables. The com­
mon APC model with A, P and C main effects has the form: 
ln(d;/NiJ) � /-< + a;+ f3; + Yk> 
with 
�a;� �/3; � �Yk � 0, 
where d,1 � number of deaths in the ij-th cell, N;j � population at 
risk, M� overall effect, and a;, /3;. Yk � age, period, and cohort ef­
fects. 
In the case of systematically changing age profiles, interaction 
terms may be required to improve the model fit and, at the same 
time, to challenge the preliminary results of the main-effect A PC 
model. Interaction effects were implemented in the APC analysis 
by means of nested effects. In nesting, we consider one or more 
cell groups within an effect type separately, imbedding therein 
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Fig. 1. Age-specific ALS mor tality rates, 
Switzerland, 1942-2008, by decennium. 
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the effects of another effect type. In APC analysis this means that 
one of the A PC effects is nested within another (e.g. study by Tan­
go and Kurashina [35]). In this study, we nested age effects within 
subperiods, thus arriving at an A(p)PC model: 
ln(d;/N;j) = fJ. +a\"')+ f3j + Yk> 
with: 
'i/3; ='in= o 
Ia\"'l = 0, m= 1, .. , M, 
where a)"') = age effects nested in m period partitions. 
APC analysis is, furthermore, hampered by the redundancy 
between linear age, period and cohort effects: any two of the three 
dimensions age, period and cohort determine the third dimen­
sion - the so-called identification problem in APC analysis. A 
simultaneous estimation of all three linear effects is not feasible 
without arbitrary additional model constraints [36). Since no so­
lution seems close at hand for the identification problem in APC 
analysis, a pragmatic procedure was chosen. Given that the age 
main-effect model typically provided a better fit than analogous 
period and cohort main-effect models, age was implemented as a 
mandatory component, and, also, as the target factor for subse­
quent constraints. Preliminary age (A) models served to derive an 
estimate for the first age group (and, similarly, each first age group 
in nested models), which was then used as a constraint in the full 
APC model. 
The model selection in APC analysis is largely data driven and 
relies mostly on the goodness of fit of the models. This is given by 
the deviance, i.e. the likelihood ratio x2 statistics and the degrees 
of freedom (d.f.). We typically compared the goodness of fit of AP, 
A(p)P, APC and A(p)PC models. The aim was to find the most 
parsimonious model fulfilling the condition that additional ef­
fects do not substantially improve the goodness of fit. 
The estimates of the A, P and C effects which are reported in 
the figures are basically defined as deviations from mean= 0; that 
is, from I after exponential transformation. In the 'Results' sec­
tion, we first discuss the goodness of fit in order to select a model, 
and then deal with the estimates of the A, P, C and nested effects. 
All analyses were carried out using the PROC CATMOD pro­
cedure of the SAS statistical package. 
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Within the period 1942-2008 there were 5,027 deaths 
with ALS registered as the underlying cause of death. For 
PD there were 17,544 deaths registered within the period 
1921-2008, and for MS, 9, 101 cases within the period 
1901-2008. Since 1969, when individual computerized 
records began, the proportion of cases registered as ad­
ditional cause of death has been 13.4% in ALS, 64.7% in 
PD and 23. 3% in MS. 
The graphic displays show two shifts in the age profiles 
of ALS (fig. 1) and PD (fig. 2) mortality rates. In contrast, 
the age profiles for MS have changed stepwise in shifts 
during the 20th century. The longitudinal representation 
of the age profiles (fig. 3) makes it clear that the mono­
tonic increase in MS rates at the beginning and end of the 
century was replaced by a curvilinear pattern in interme­
diate periods. 
The model selection in APC analysis turned out to be 
most difficult in ALS data. Both the main effect APC 
model (fig. 4, dashed line; deviance 15.0, d.f. 10) and the 
nested A(p)PC model (deviance 19.8, d.f. 6) worked simi­
larly well. However, they did not provide a clear improve­
ment as compared with the more parsimonious A(p)P 
model (deviance 25.5, d.f. 12). Thus, it seems unlikely that 
cohort effects play an important role in ALS. From this 
standpoint, the nested age effects represent two steps of 
change in age patterns in ALS mortality. Instead of the 
curvilinear pattern from the mid 20th century we see a 
steep increase at the end of the century. Including nested 
effects led to the period effects pattern becoming reversed 
and at the same time smoother. 
Model selection in the APC analysis of PD data (fig. 5) 
clearly pointed to the A(p)PC model, whose fit (deviance 
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Fig. 2. Age-specific PO mortality rates, 
Switzerland, 1921·2008, by decennium. 
Fig. 3. Age-specific MS mortality rates, 
Switzerland, 1901-2008, by decennium. 
Fig. 4. A PC: analysis of Swiss ALS mortal­
ity data, 1942-2008: estimates of the main 
effect A PC: model (dashed line), the A(p)P 
model including nested effects (bold line) 
and the A(p)PC: model including nested ef­
fects (thin line). The A and P estimates of 
the latter models overlay each other since 
they are almost identical. 
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62.5, d.f. 10) was superior to that of the APC model (devi­
ance 108.3, d.f. 14) and other models. Just as with ALS, 
the age patterns became steeper in the second half of the 
20th century and ended up with a steep increase around 
2000. As another parallel, the period and birth cohort es­
timates smoothed out in the nested model; however, they 
did not change patterns. The period estimates indicate 
that PD mortality increased in the 1920-1930s and later 
since the 1990s. In addition, the analysis showed that 
birth cohorts born between 1870 and 1920 lived with an 
increased risk of developing PD. 
In MS (fig. 6), the comparison of model fits favored the 
main effect APC model (deviance of 36.7 with d.f. 27 ) 
over the A(p)PC model [deviance of 39.0 with d.f. 21 (and 
3 fixed estimates instead of 1)]. Moreover, the period and 
birth cohort estimates did not smooth out as with ALS 
and PD. The period estimates were low at the beginning 
of the 20th century, and, after an intermediate period, 
have decreased markedly since the 1960s. Finally, the 
birth cohorts carrying an enhanced risk of MS were born 
between 1890 and 1930, with the peak occurring in Swit­
zerland around 1910-1920. 
60 Neuroepidemiology 2012;38:56-63 
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Discussion 
This study examined birth cohort effects in three neu­
rological diseases (ALS, PD, MS) by means of APC anal­
ysis extended by nested effects. The analyses were based 
on Swiss mortality data. Birth cohort effects in ALS were 
ambiguous, and could be putatively replaced by nested 
effects (age effects nested in periods). In PD, the effects 
were increased in cohorts born before the 1920s. Finally, 
we found distinct and stable birth cohort effects in MS 
with a peak occurring around the years 1910-1920. 
Amyotrophic Lateral Sclerosis 
The etiopathogenetic hypotheses regarding ALS 
pathogenesis sometimes include the mechanism of pre­
disposing risk factors, and a latency period, for example 
following the polio model [37]. However, full APC analy­
ses have not yet been applied in the epidemiology of ALS. 
The descriptive study by Li et al. [8] found some evidence 
for birth cohort effects from descriptive analyses of UK 
mortality data. Moreover, several analyses of the age 
structure sought to show whether changes in ALS inci­
dence/mortality are real, or have an artificial background, 
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effect A PC model (clashed line) and the 
A(p)PC model including nested effects 
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0 --1.5 
due for example to prolongation of life expectancy [15, 
38-40]. The results were not uniform and differed by 
country. 
The APC analysis of Swiss ALS data also yielded 
equivocal results. While the APC model with main ef­
fects returned a slightly better model fit, the A(p)P mod­
el (age effects nested into three subperiods) was more par­
simonious. This model also seems to be more appropriate 
in view of the age patterns in ALS (fig. 1). However, it re­
mains to be seen whether further analyses will support 
this interpretation. 
Parkinson's Disease 
The study by Poskanzer and Schwab [24] in 1963 was 
the first to introduce the issue of birth cohort analysis in 
neuroepidemiology. It focused on the role of the enceph­
alitis lethargica epidemics of the 1920s as a risk factor for 
PD, which could trigger PD not only in a direct but also 
in a delayed manner. 
In this study, the birth cohort effects in PD smoothed 
out after nested age effects were included in the model. 
The change in age patterns was similar to that in ALS, 
even if the cause does not need to be the same. There are 
Birth Cohort Effects in Neurological 
Diseases 
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several hypothetical explanations: a prolongation of life 
expectancy in patients due to better treatment and care, 
a prolongation of life expectancy in diseases sharing the 
same risk factors (so that more persons get PD), a change 
in registration practice giving PD a higher registration 
priority. Finally, the birth cohorts born before the en­
cephalitis lethargica epidemics carried the highest esti­
mates. 
Multiple Sclerosis 
Many etiopathogenetic hypotheses in MS focus on the 
role of noxes, such as infectious diseases occurring in 
childhood or youth [41]. The latency period between the 
occurrence of risk factors and MS onset has been dis­
cussed in depth [42]. Therefore, and in addition to the 
indirect evidence deriving from changing rates and sea­
son of birth issues, it was not contradictory to encounter 
birth cohort trends in MS in this study. 
Preliminary APC analyses [12], and analyses using a 
similar APC approach, which have been carried out with 
Swedish data [9], and also with Spanish data [10], have 
yielded similar results. Analyses using a descriptive ap­
proach [8] or regional data [11] have been less conclusive. 
Neuroepidemiology 2012;38:56-63 61 
In Switzerland, the cohorts born around 1910-1920 car­
ried the highest risk of MS throughout their lives. The 
background of these cohort effects is unclear, since none 
of the known risk factors [41, 43, 44] seems to be a suit­
able candidate in providing a plausible link for the inter­
pretation: smoking, Epstein-Barr virus, other viruses, ex­
posure to organic solvents, physical trauma, obesity and, 
finally, psychological distress. The same applies to sus­
pected protective factors such as sunlight exposure/vita­
min D, use of antibiotics and antihistamines, and dietary 
factors (such as n-3 polyunsaturated fat linoleic acid). 
In contrast, the interpretation of period effects is 
somewhat easier. At the beginning of the 20th century, 
MS was doubtless underreported, which explains the low 
period estimates of that time [45]. The downward trend 
since the 1960s is most probably due to the improving life 
expectancy of MS patients, notably after the broad intro­
duction of antibiotics in medical treatment. 
Technical Remarks and Limitations 
One of the peculiarities of APC analyses which are 
based on conventional cohort tables (age X period tables) 
is that the birth cohort effects provide only an approxi­
mate resolution. For example, in tables with 10-year age 
groups and 1 0-year periods (as used in this analysis), a 
single cell of the data matrix spans a cohort of 19 birth 
years. This means that the birth cohorts in the APC anal­
ysis overlap, i.e. represent in fact weighted moving aver­
ages, which results in smoothed estimates. This clearly 
limits the potential of APC analysis: it is not possible to 
make conclusions about eventual short-term f luctuations 
in birth cohort effects, for example generated by any ex­
traordinary epidemics or other sudden changes in predis­
posing risk factors. 
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